Apalutamide's FDA-approval is discussed, including discussion of its drug interaction potential and a review of the SPARTAN study. Updates (18:15) from ASCO GU and DOAC use in cancer (23:50) also discussed.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
